NCT07441850Recruiting
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
The Effect of Perioperative Rehabilitation Programme Delivered Via a Smart Phone Based Digital Platform in Patients Undergoing Neoadjuvant Therapy for Gastric Cancer Surgery: Study Protocol for a Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is to investigate the effects of a perioperative multimodal rehabilitation program on the incidence of postoperative complications and perioperative clinical indexes including functional capacity, nutritional and psychological status in patients with gastric cancer undergoing neoadjuvant therapy. Besides the investigators also develop a smart phone based digital platform aiming to evaluate its effectiveness in improving patient adherence, compared with the conventional telephone supervision approach. The main questions it aims to answer are: * Can the perioperative multimodal rehabilitation program reduce postoperative complications in patients with gastric cancer undergoing neoadjuvant therapy? * Can the smart phone based digital platform improve patients' adherence compared to traditional telephone supervision? * Can the perioperative multimodal rehabilitation program improve the perioperative clinical indicators of patients with gastric cancer undergoing neoadjuvant therapy, including functional capacity, nutritional status and psychological condition? The investigators will compare the perioperative multimodal rehabilitation program with the standard treatment alone to determine whether this program has the effects mentioned above. Participants will follow the perioperative multimodal rehabilitation program from neoadjuvant therapy through to four weeks after discharge.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 186 (estimated)
- First submitted
- 3 Feb 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Beijing Friendship Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07441850
What you commit to
- Study type: Interventional
- Planned participants: 186
- From 1 Mar 2026 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concurrent other malignant tumours;
Other illness
- severe cardiopulmonary disease or other contraindications precluding completion of the 6MWT or participation in exercise training;
- suspected recurrent gastric cancer;
- cognitive impairment, communication barriers, or psychiatric conditions that would prevent compliance with the study procedures;
Other
- presence of distant metastasis;
- women who are pregnant, lactating, or planning a pregnancy.
Who the study is looking for
- patients aged between 18 and 70 years;
- patients with histologically confirmed resectable adenocarcinoma of the oesophago gastric junction or stomach;
- patients referred by a multidisciplinary team (MDT) for neoadjuvant therapy;
- patients able to use a smartphone and the digital follow up platform, and willing to comply with regular follow up assessments;
- patients who provide written informed consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Friendship Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.